<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK459118" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK459118/" /><meta name="ncbi_pagename" content="Poikiloderma with Neutropenia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Poikiloderma with Neutropenia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Poikiloderma with Neutropenia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/10/26" /><meta name="citation_author" content="Lisa Wang" /><meta name="citation_author" content="Carol Clericuzio" /><meta name="citation_author" content="Lidia Larizza" /><meta name="citation_pmid" content="29072891" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK459118/" /><meta name="citation_keywords" content="Clericuzio-Type Poikiloderma with Neutropenia" /><meta name="citation_keywords" content="Clericuzio-Type Poikiloderma with Neutropenia" /><meta name="citation_keywords" content="U6 snRNA phosphodiesterase" /><meta name="citation_keywords" content="USB1" /><meta name="citation_keywords" content="Poikiloderma with Neutropenia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Poikiloderma with Neutropenia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lisa Wang" /><meta name="DC.Contributor" content="Carol Clericuzio" /><meta name="DC.Contributor" content="Lidia Larizza" /><meta name="DC.Date" content="2017/10/26" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK459118/" /><meta name="description" content="Poikiloderma with neutropenia (PN) is characterized by an inflammatory eczematous rash (ages 6-12 months) followed by post-inflammatory poikiloderma (age &gt;2 years) and chronic noncyclic neutropenia typically associated with recurrent sinopulmonary infections in the first two years of life and (often) bronchiectasis. There is increased risk for myelodysplastic syndrome and, rarely, acute myelogenous leukemia. Other ectodermal findings include nail dystrophy and palmar/plantar hyperkeratosis. Most affected individuals also have reactive airway disease and some have short stature, hypogonadotropic hypogonadism, midfacial retrusion, calcinosis cutis, and non-healing skin ulcers." /><meta name="og:title" content="Poikiloderma with Neutropenia" /><meta name="og:type" content="book" /><meta name="og:description" content="Poikiloderma with neutropenia (PN) is characterized by an inflammatory eczematous rash (ages 6-12 months) followed by post-inflammatory poikiloderma (age &gt;2 years) and chronic noncyclic neutropenia typically associated with recurrent sinopulmonary infections in the first two years of life and (often) bronchiectasis. There is increased risk for myelodysplastic syndrome and, rarely, acute myelogenous leukemia. Other ectodermal findings include nail dystrophy and palmar/plantar hyperkeratosis. Most affected individuals also have reactive airway disease and some have short stature, hypogonadotropic hypogonadism, midfacial retrusion, calcinosis cutis, and non-healing skin ulcers." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK459118/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/poikiloderma-n/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK459118/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A6614E040AE610000000003FE018D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK459118_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK459118_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pitt-hopkins/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pkd-ad/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK459118_"><span class="title" itemprop="name">Poikiloderma with Neutropenia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Clericuzio-Type Poikiloderma with Neutropenia</div><p class="contrib-group"><span itemprop="author">Lisa Wang</span>, MD, <span itemprop="author">Carol Clericuzio</span>, MD, and <span itemprop="author">Lidia Larizza</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK459118_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK459118_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lisa Wang</span>, MD<div class="affiliation small">Department of Pediatrics<br />Hematology/Oncology<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.mcb@gnawll" class="oemail">gro.mcb@gnawll</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Carol Clericuzio</span>, MD<div class="affiliation small">Emeritus Professor of Pediatrics<br />Division of Pediatric Genetics<br />University of New Mexico School of Medicine<br />Albuquerque, New Mexico<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mnu.dulas@oizucirelcc" class="oemail">ude.mnu.dulas@oizucirelcc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lidia Larizza</span>, MD<div class="affiliation small">Research Director, Laboratory of Medical Cytogenetics &#x00026; Genetics<br />IRCSS Istituto Auxologico Italiano<br />Milan, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ocigoloxua@azziral.l" class="oemail">ti.ocigoloxua@azziral.l</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 26, 2017</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="poikiloderma-n.Summary" itemprop="description"><h2 id="_poikiloderma-n_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Poikiloderma with neutropenia (PN) is characterized by an inflammatory eczematous rash (ages 6-12 months) followed by post-inflammatory poikiloderma (age &#x0003e;2 years) and chronic noncyclic neutropenia typically associated with recurrent sinopulmonary infections in the first two years of life and (often) bronchiectasis. There is increased risk for myelodysplastic syndrome and, rarely, acute myelogenous leukemia. Other ectodermal findings include nail dystrophy and palmar/plantar hyperkeratosis. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals also have reactive airway disease and some have short stature, hypogonadotropic hypogonadism, midfacial retrusion, calcinosis cutis, and non-healing skin ulcers.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Often the diagnosis of PN can be established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> based on clinical findings (post-inflammatory poikiloderma and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> chronic neutropenia). Unequivocal confirmation of the diagnosis of PN relies on detection of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>USB1</i> pathogenic variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Dermatologic manifestations are treated with gentle skin care using bland emollients and diligent sun protection; very pruritic palmar/plantar hyperkeratosis can be treated with a strong topical steroid or a topical keratolytic if secondary dermatophyte infection has been ruled out. Although use of granulocyte-colony stimulating factor (G-CSF) increases the absolute neutrophil count, there is little evidence of its clinical effect (such as decreased frequency of infections). Myelodysplastic syndrome and acute myelogenous leukemia are treated in the usual manner. Sinopulmonary, middle ear, and skin infections require aggressive treatment with antibiotics. Reactive airway disease and hypogonadotropic hypogonadism are treated in the usual manner.</p><p><i>Prevention of secondary complications:</i> Annual influenza vaccine; dental cleaning and evaluation for gingivitis/caries every three to six months; liberal use of sunscreens with both UVA and UVB protection to reduce the risk of skin cancer.</p><p><i>Surveillance:</i> Annual evaluation:</p><ul><li class="half_rhythm"><div>By a physician familiar with PN of CBC with differential and platelet count (for evidence of anemia and/or thrombocytopenia &#x02012; signs of possible myelodysplastic syndrome);</div></li><li class="half_rhythm"><div>By a pulmonologist for those with bronchiectasis, chronic cough, and/or reactive airway disease;</div></li><li class="half_rhythm"><div>By a dermatologist (starting at age 10 years) for skin cancer screening.</div></li></ul><p>In children: routine monitoring of growth, developmental milestones, school progress, and pubertal development.</p><p><i>Agents/circumstances to avoid:</i> Excessive sun exposure (to decrease risk of skin cancer); exposure to second-hand cigarette or wood smoke and persons with respiratory illnesses (to decrease the risk of respiratory infections).</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to evaluate apparently asymptomatic older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from prompt initiation of treatment and surveillance for potential complications.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>PN is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>USB1</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="poikiloderma-n.Diagnosis"><h2 id="_poikiloderma-n_Diagnosis_">Diagnosis</h2><div id="poikiloderma-n.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Poikiloderma with neutropenia (PN) <b>should be suspected</b> in individuals with the following clinical findings and laboratory findings.</p><div id="poikiloderma-n.Clinical"><h4>Clinical</h4><p><b>Skin</b></p><ul><li class="half_rhythm"><div>Between ages six and 12 months, inflammatory eczematous rash appearing first on the limbs and progressing to the trunk, face, and on occasion the pinnae</div></li><li class="half_rhythm"><div>After age two years, post-inflammatory poikiloderma (areas of hyper- and hypopigmentation, atrophy, and telangiectasias) (<a class="figpopup" href="/books/NBK459118/figure/poikiloderma-n.F1/?report=objectonly" target="object" rid-figpopup="figpoikilodermanF1" rid-ob="figobpoikilodermanF1">Figure 1</a>). Note: The telangiectasia may be subclinical and seen only on skin biopsy (which is not necessary for diagnosis).</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpoikilodermanF1" co-legend-rid="figlgndpoikilodermanF1"><a href="/books/NBK459118/figure/poikiloderma-n.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figpoikilodermanF1" rid-ob="figobpoikilodermanF1"><img class="small-thumb" src="/books/NBK459118/bin/poikiloderma-n-Image001.gif" src-large="/books/NBK459118/bin/poikiloderma-n-Image001.jpg" alt="Figure 1. . Post-inflammatory poikiloderma in a boy age ten years; note hypo- and hyperpigmentation." /></a><div class="icnblk_cntnt" id="figlgndpoikilodermanF1"><h4 id="poikiloderma-n.F1"><a href="/books/NBK459118/figure/poikiloderma-n.F1/?report=objectonly" target="object" rid-ob="figobpoikilodermanF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Post-inflammatory poikiloderma in a boy age ten years; note hypo- and hyperpigmentation. </p></div></div><p><b>Recurrent infections (as evidence of neutropenia)</b></p><ul><li class="half_rhythm"><div>In the first two years of life, recurrent sinopulmonary infections &#x02012; often complicated by bronchiectasis</div></li><li class="half_rhythm"><div>Adolescent- and adult-onset non-healing skin ulcers</div></li></ul></div><div id="poikiloderma-n.Laboratory"><h4>Laboratory</h4><p><b>Congenital chronic noncyclic neutropenia</b> that is moderate to severe:</p><ul><li class="half_rhythm"><div>Moderate neutropenia: absolute neutrophil count (ANC)* 500-1000/&#x000b5;L</div></li><li class="half_rhythm"><div>Severe neutropenia: ANC &#x0003c;500/ &#x000b5;L</div></li></ul><p>* ANC = white blood cell count (WBC) x % neutrophils</p></div></div><div id="poikiloderma-n.Establishing_the_Diagnosi"><h3>Establishing the Diagnosis</h3><p>In many instances, the diagnosis of poikiloderma with neutropenia (PN) <b>is established</b> clinically in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with post-inflammatory poikiloderma and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> chronic neutropenia. Unequivocal confirmation of the diagnosis of PN in individuals with a suspected clinical diagnosis or findings consistent with PN relies on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> demonstrating <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>USB1</i> pathogenic variants (<a class="figpopup" href="/books/NBK459118/table/poikiloderma-n.T.molecular_genetic_testi/?report=objectonly" target="object" rid-figpopup="figpoikilodermanTmoleculargenetictesti" rid-ob="figobpoikilodermanTmoleculargenetictesti">Table 1</a>) [<a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.piard.2012.8">Piard et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.larizza.2013.21">Larizza et al 2013</a>].</p><p>Molecular genetic testing approaches depend on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing or a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Persons with the distinctive findings described in <a href="#poikiloderma-n.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing, whereas those in whom a specific diagnosis has been elusive are more likely to be diagnosed using genomic testing.</p><p><b>Gene-targeted testing</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>USB1</i> (formerly <i>C16orf57</i>) is performed first. To date <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> has detected <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in all tested individuals with a clinical diagnosis of poikiloderma with neutropenia. To date, no <i>USB1</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions have been reported.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>USB1</i> and other genes of interest (see <a href="#poikiloderma-n.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Of note, given the rarity of poikiloderma with neutropenia many custom panels for pigmentary skin disorders and neutropenia may not include <i>USB1</i>.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><p><b>Genomic testing</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="poikiloderma-n.T.molecular_genetic_testi" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Poikiloderma with Neutropenia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK459118/table/poikiloderma-n.T.molecular_genetic_testi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__poikiloderma-n.T.molecular_genetic_testi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>USB1</i></td><td headers="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All probands reported to date&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_poikiloderma-n.T.molecular_genetic_testi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="poikiloderma-n.TF.1.1"><p class="no_margin">See <a href="/books/NBK459118/#poikiloderma-n.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="poikiloderma-n.TF.1.2"><p class="no_margin">See <a href="#poikiloderma-n.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="poikiloderma-n.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="poikiloderma-n.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#poikiloderma-n.REF.arnold.2010.866">Arnold et al [2010]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.tanaka.2010.1347">Tanaka et al [2010]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.volpi.2010.72">Volpi et al [2010]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al [2010]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.clericuzio.2011.337">Clericuzio et al [2011]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al [2012]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.piard.2012.8">Piard et al [2012]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.farruggia.2014.297">Farruggia et al [2014]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.koparir.2014.2535">Koparir et al [2014]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.patiroglu.2015.331">Patiroglu &#x00026; Akar [2015]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.kilic.2016.e75">Kilic &#x00026; Cekic [2016]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.suter.2016.359">Suter et al [2016]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2016.1180">Walne et al [2016]</a>, <a class="bk_pop" href="#poikiloderma-n.REF.aglaguel.2017.357">Aglaguel et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="poikiloderma-n.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="poikiloderma-n.TF.1.6"><p class="no_margin">To date, no <i>USB1</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions have been reported.</p></div></dd></dl></div></div></div></div></div><div id="poikiloderma-n.Clinical_Characteristics"><h2 id="_poikiloderma-n_Clinical_Characteristics_">Clinical Characteristics</h2><div id="poikiloderma-n.Clinical_Description"><h3>Clinical Description</h3><p>Poikiloderma with neutropenia (PN) is characterized by post-inflammatory poikiloderma and chronic noncyclic neutropenia typically associated with recurrent sinopulmonary infections and (often) bronchiectasis. There is increased risk for myelodysplastic syndrome and, rarely, acute myelogenous leukemia. Other ectodermal findings include nail dystrophy (typically, thickened nails) and palmar/plantar hyperkeratosis. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals also have reactive airway disease and some have short stature, hypogonadotropic hypogonadism, midfacial retrusion, calcinosis cutis, and non-healing skin ulcers [<a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>].</p><p>Intrafamilial clinical variability of findings of midfacial hypoplasia, poikiloderma, and neutropenia [<a class="bk_pop" href="#poikiloderma-n.REF.concolino.2010.2588">Concolino et al 2010</a>] and pulmonary involvement [<a class="bk_pop" href="#poikiloderma-n.REF.patiroglu.2015.331">Patiroglu &#x00026; Akar 2015</a>] has been observed &#x02012; the most significant instance being acute myelogenous leukemia observed in one of two sibs [<a class="bk_pop" href="#poikiloderma-n.REF.porter.1999.452">Porter et al 1999</a>].</p><p>The clinical information that follows is based on more than 70 individuals (published and unpublished to date) with a clinical diagnosis of PN.</p><div id="poikiloderma-n.Ectodermal_Features"><h4>Ectodermal Features</h4><p><b>Skin.</b> The skin is normal at birth. At age six to 12 months, a nonpruritic acral eczematous-like rash develops which progresses to the trunk and face. Over the next year or so the inflammatory rash resolves, the skin becomes dry, and poikiloderma becomes evident as areas of hyper- and hypopigmentation, atrophy, and telangiectasias (<a class="figpopup" href="/books/NBK459118/figure/poikiloderma-n.F1/?report=objectonly" target="object" rid-figpopup="figpoikilodermanF1" rid-ob="figobpoikilodermanF1">Figure 1</a>).</p><p>Poikiloderma persists throughout life and may be more noticeable in individuals who have constitutionally darker skin.</p><p>Palmar/plantar hyperkeratosis is common.</p><p>Calcinosis cutis &#x02013; small nodules that may be localized to the elbows, knees, and pinnae or more diffuse &#x02013; may develop in childhood [<a class="bk_pop" href="#poikiloderma-n.REF.chantorn.2012.463">Chantorn &#x00026; Shwayder 2012</a>].</p><p>Children and adults are prone to cellulitis (a manifestation of neutropenia) that may progress to non-healing skin ulcers.</p><p>Photosensitivity has been reported in some.</p><p>Squamous cell carcinoma of the skin was reported in two individuals: one age 14 years [<a class="bk_pop" href="#poikiloderma-n.REF.rodgers.2013.665">Rodgers et al 2013</a>] and the other "at a young age" [<a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>].</p><p><b>Nails.</b> Thickened, hyperkeratotic toenails are common; dystrophic nails which can slough may also be seen (<a class="figpopup" href="/books/NBK459118/figure/poikiloderma-n.F2/?report=objectonly" target="object" rid-figpopup="figpoikilodermanF2" rid-ob="figobpoikilodermanF2">Figure 2</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpoikilodermanF2" co-legend-rid="figlgndpoikilodermanF2"><a href="/books/NBK459118/figure/poikiloderma-n.F2/?report=objectonly" target="object" title="Figure 2" class="img_link icnblk_img figpopup" rid-figpopup="figpoikilodermanF2" rid-ob="figobpoikilodermanF2"><img class="small-thumb" src="/books/NBK459118/bin/poikiloderma-n-Image002.gif" src-large="/books/NBK459118/bin/poikiloderma-n-Image002.jpg" alt="Figure 2. A." /></a><div class="icnblk_cntnt" id="figlgndpoikilodermanF2"><h4 id="poikiloderma-n.F2"><a href="/books/NBK459118/figure/poikiloderma-n.F2/?report=objectonly" target="object" rid-ob="figobpoikilodermanF2">Figure 2</a></h4><p class="float-caption no_bottom_margin">A. Nail dystrophy in a girl age five years B. Dysplastic toenails and squamous cell carcinoma (blue arrow) in a girl age 14 years</p></div></div><p><b>Hair.</b> Eyebrows and eyelashes can be sparse; hair can be dry and thin.</p><p><b>Teeth.</b> Delayed dental eruption and abscesses have been observed. Gingivitis and dental caries leading to tooth loss are common.</p></div><div id="poikiloderma-n.Hematologic_Findings"><h4>Hematologic Findings</h4><p><b>Neutropenia.</b> Neutropenia is usually identified in early infancy associated with recurrent sinopulmonary infections, often complicated by bronchiectasis.</p><p>Most individuals with PN who are not acutely ill have moderate neutropenia; although some have severe neutropenia [<a class="bk_pop" href="#poikiloderma-n.REF.van_hove.2005.152">Van Hove et al 2005</a>, <a class="bk_pop" href="#poikiloderma-n.REF.farruggia.2014.297">Farruggia et al 2014</a>]. While the absolute neutrophil count (ANC) may rise to the low-normal range during acute infection, it is always inappropriately low and with resolution of the infection reverts to baseline neutropenia.</p><p><b>Transient thrombocytopenia and variable anemia</b> have been reported [<a class="bk_pop" href="#poikiloderma-n.REF.van_hove.2005.152">Van Hove et al 2005</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.clericuzio.2011.337">Clericuzio et al 2011</a>, <a class="bk_pop" href="#poikiloderma-n.REF.farruggia.2014.297">Farruggia et al 2014</a>].</p></div><div id="poikiloderma-n.Myelodysplasia_and_Hemato"><h4>Myelodysplasia and Hematologic Malignancies</h4><p>Of 26 persons with PN without a known malignancy, bone marrow studies showed:</p><ul><li class="half_rhythm"><div>24 with premyelodysplastic changes (often defined as &#x0003c;10% abnormal cells) including increased number of immature cells and myeloid maturation defects [<a class="bk_pop" href="#poikiloderma-n.REF.van_hove.2005.152">Van Hove et al 2005</a>, <a class="bk_pop" href="#poikiloderma-n.REF.mostefai.2008.2762">Mostefai et al 2008</a>, <a class="bk_pop" href="#poikiloderma-n.REF.concolino.2010.2588">Concolino et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.tanaka.2010.1347">Tanaka et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.clericuzio.2011.337">Clericuzio et al 2011</a>, <a class="bk_pop" href="#poikiloderma-n.REF.farruggia.2014.297">Farruggia et al 2014</a>, <a class="bk_pop" href="#poikiloderma-n.REF.patiroglu.2015.331">Patiroglu &#x00026; Akar 2015</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2016.1180">Walne et al 2016</a>];</div></li><li class="half_rhythm"><div>Two with a normal pattern.</div></li></ul><p>In five additional persons with PN:</p><ul><li class="half_rhythm"><div>Three had myelodysplastic syndrome [<a class="bk_pop" href="#poikiloderma-n.REF.pianigiani.2001.422">Pianigiani et al 2001</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2016.1180">Walne et al 2016</a>];</div></li><li class="half_rhythm"><div>Two had acute myelogenous leukemia [<a class="bk_pop" href="#poikiloderma-n.REF.porter.1999.452">Porter et al 1999</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>].</div></li></ul></div><div id="poikiloderma-n.Infection"><h4>Infection</h4><p>Almost 90% of individuals with PN have recurrent pulmonary infections including bronchiectasis, lung abscesses, and lung granulomas. Chronic recurrent otitis media and sinusitis are common in childhood.</p><p>After age five to ten years, the frequency of acute sinopulmonary infections decreases, but most individuals continue to have bronchiectasis, chronic non-productive cough, and reactive airway disease.</p><p>Quantitative immunoglobulins and lymphocyte subset panels are normal.</p></div><div id="poikiloderma-n.Facial_Features"><h4>Facial Features</h4><p>Facial features are normal at birth; however, over time characteristic craniofacial features of prominent forehead, depressed nasal bridge, and midface retrusion usually develop (<a class="figpopup" href="/books/NBK459118/figure/poikiloderma-n.F3/?report=objectonly" target="object" rid-figpopup="figpoikilodermanF3" rid-ob="figobpoikilodermanF3">Figure 3</a>) [<a class="bk_pop" href="#poikiloderma-n.REF.concolino.2010.2588">Concolino et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.koparir.2014.2535">Koparir et al 2014</a>].</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpoikilodermanF3" co-legend-rid="figlgndpoikilodermanF3"><a href="/books/NBK459118/figure/poikiloderma-n.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figpoikilodermanF3" rid-ob="figobpoikilodermanF3"><img class="small-thumb" src="/books/NBK459118/bin/poikiloderma-n-Image003.gif" src-large="/books/NBK459118/bin/poikiloderma-n-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndpoikilodermanF3"><h4 id="poikiloderma-n.F3"><a href="/books/NBK459118/figure/poikiloderma-n.F3/?report=objectonly" target="object" rid-ob="figobpoikilodermanF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Three Italian sibs with typical midfacial hypoplasia </p></div></div></div><div id="poikiloderma-n.Other_Findings"><h4>Other Findings</h4><p><b>Common.</b> Birth length and weight are usually normal; however, intrauterine growth restriction (IUGR) can be seen. Postnatal-onset short stature not associated with growth hormone deficiency is common. One individual was reported to be unresponsive to growth hormone therapy [<a class="bk_pop" href="#poikiloderma-n.REF.koparir.2014.2535">Koparir et al 2014</a>].</p><p>Virtually all individuals have elevated serum lactate dehydrogenase of unknown etiology; some have nonspecific mild elevation of aminotransferases, aspartate aminotransferase, ferritin, and creatine phosphokinase.</p><p>Hypogonadotropic hypogonadism causing delayed puberty is common.</p><p>Both osteopenia and increased bone density have been reported [<a class="bk_pop" href="#poikiloderma-n.REF.migliaccio.1999.834">Migliaccio et al 1999</a>, <a class="bk_pop" href="#poikiloderma-n.REF.porter.1999.452">Porter et al 1999</a>, <a class="bk_pop" href="#poikiloderma-n.REF.wang.2003.299">Wang et al 2003</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.koparir.2014.2535">Koparir et al 2014</a>]. Associated features include increased bone fragility and osteoporosis. Two individuals who are older than age 30 years have been followed long term for poorly healing long bone fractures [<a class="bk_pop" href="#poikiloderma-n.REF.volpi.2010.72">Volpi et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>].</p><p>Although early developmental delays (possibly related to chronic illness) have been reported, intellectual disability has not been reported.</p><p>Several patients with muscle weakness had normal muscle biopsies.</p><p><b>Rare</b></p><ul><li class="half_rhythm"><div>Epiphora due to lacrimal duct obstruction and vocal cord nodules with hyperkeratinization, resulting in high-pitched voice [<a class="bk_pop" href="#poikiloderma-n.REF.koparir.2014.2535">Koparir et al 2014</a>]</div></li><li class="half_rhythm"><div>Macrocephaly and microcephaly</div></li><li class="half_rhythm"><div>Hepatosplenomegaly</div></li><li class="half_rhythm"><div>Hypermobile fingers with "swan neck deformity"</div></li></ul></div></div><div id="poikiloderma-n.GenotypePhenotype_Correla"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations have not been established to date.</p></div><div id="poikiloderma-n.Nomenclature"><h3>Nomenclature</h3><p>Poikiloderma with neutropenia was termed "immune-deficient poikiloderma" in the publication by <a class="bk_pop" href="#poikiloderma-n.REF.clericuzio.1991.a661">Clericuzio et al [1991]</a>, who first described the condition in the Navajo population. When it was subsequently reported in non-Navajo individuals, the condition was renamed poikiloderma with neutropenia [<a class="bk_pop" href="#poikiloderma-n.REF.wang.2003.299">Wang et al 2003</a>].</p><p>In 2005 Van Hove proposed renaming the disorder Clericuzio-type poikiloderma with neutropenia [<a class="bk_pop" href="#poikiloderma-n.REF.van_hove.2005.152">Van Hove et al 2005</a>].</p></div><div id="poikiloderma-n.Prevalence"><h3>Prevalence</h3><p>First described in the Navajo native American population [<a class="bk_pop" href="#poikiloderma-n.REF.clericuzio.1991.a661">Clericuzio et al 1991</a>], poikiloderma with neutropenia has since been identified in non-Navajos worldwide, including a substantial number of individuals of Turkish ancestry.</p></div></div><div id="poikiloderma-n.Genetically_Related_Allel"><h2 id="_poikiloderma-n_Genetically_Related_Allel_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than poikiloderma with neutropenia are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>USB1</i>.</p></div><div id="poikiloderma-n.Differential_Diagnosis"><h2 id="_poikiloderma-n_Differential_Diagnosis_">Differential Diagnosis</h2><p><a class="figpopup" href="/books/NBK459118/table/poikiloderma-n.T.disorders_to_consider_i/?report=objectonly" target="object" rid-figpopup="figpoikilodermanTdisorderstoconsideri" rid-ob="figobpoikilodermanTdisorderstoconsideri">Table 2</a> summarizes inherited disorders with either poikiloderma or neutropenia in the differential diagnosis of poikiloderma with neutropenia (PN). While there is clinical overlap between PN and dyskeratosis congenita (DC) and Rothmund-Thomson syndrome (RTS), PN is clinically distinguishable from these two disorders (<a class="figpopup" href="/books/NBK459118/table/poikiloderma-n.T.disorders_to_consider_i/?report=objectonly" target="object" rid-figpopup="figpoikilodermanTdisorderstoconsideri" rid-ob="figobpoikilodermanTdisorderstoconsideri">Table 2</a>).</p><p>Of note, several individuals who were clinically misdiagnosed as either DC or RTS in the past have been correctly diagnosed as having PN following identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>USB1</i> variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> [<a class="bk_pop" href="#poikiloderma-n.REF.volpi.2010.72">Volpi et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2016.1180">Walne et al 2016</a>].</p><div id="poikiloderma-n.T.disorders_to_consider_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Poikiloderma with Neutropenia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK459118/table/poikiloderma-n.T.disorders_to_consider_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__poikiloderma-n.T.disorders_to_consider_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_1" rowspan="3" scope="col" colspan="1" headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_2" rowspan="3" scope="col" colspan="1" headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_3" rowspan="3" scope="col" colspan="1" headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Features</th></tr><tr><th headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_1" id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_1" rowspan="2" colspan="1" scope="colgroup" style="text-align:left;vertical-align:middle;">Overlapping with PN</th><th headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4" id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Distinguishing</th></tr><tr><th headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2" id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_3_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">In this disorder</th><th headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2" id="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_3_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In PN</th></tr></thead><tbody><tr><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dkc/">Dyskeratosis congenita</a></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACD</i><br /><i>CTC1</i><br /><i>DKC1</i><br /><i>NHP2</i><br /><i>NOP10</i><br /><i>PARN</i><br /><i>RTEL1</i><br /><i>TERC</i><br /><i>TERT</i><br /><i>TINF2</i><br /><i>WRAP53</i></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL<br />AD<br />AR</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Poikiloderma</div></li><li class="half_rhythm"><div>Nail dystrophy</div></li><li class="half_rhythm"><div>Myelodysplasia</div></li><li class="half_rhythm"><div>AML</div></li></ul>
</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Poikiloderma upper chest/neck</div></li><li class="half_rhythm"><div>Oral leukoplakia</div></li><li class="half_rhythm"><div>Pulmonary fibrosis</div></li><li class="half_rhythm"><div>Short telomeres (on lab testing)</div></li></ul>
</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_3_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Generalized (extremities &#x00026; central body) post-inflammatory poikiloderma in infancy/early childhood</div></li><li class="half_rhythm"><div>Nail dystrophy</div></li><li class="half_rhythm"><div>Congenital chronic moderate neutropenia</div></li><li class="half_rhythm"><div>Recurrent upper-respiratory infections</div></li></ul>
</td></tr><tr><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rts/">Rothmund-Thomson syndrome</a></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RECQL4</i></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early-onset poikiloderma at extremities</div></li><li class="half_rhythm"><div>Palmar/plantar hyperkeratosis</div></li><li class="half_rhythm"><div>Nail dystrophy</div></li><li class="half_rhythm"><div>Sparse hair &#x00026; eyebrows/lashes</div></li><li class="half_rhythm"><div>Dental abnormalities</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>SCC skin</div></li></ul>
</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early-onset facial poikiloderma</div></li><li class="half_rhythm"><div>Skeletal defects (incl radial ray defects)</div></li><li class="half_rhythm"><div>Gastrointestinal disturbance</div></li><li class="half_rhythm"><div>Osteosarcoma</div></li></ul>
</td></tr><tr><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hfpoik-tmp/">Hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP)</a></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FAM111B</i></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Sparse/absent eyelashes and/or eyebrows</div></li><li class="half_rhythm"><div>Poikiloderma</div></li><li class="half_rhythm"><div>Nail dysplasia</div></li><li class="half_rhythm"><div>Palmar/plantar hyperkeratosis</div></li><li class="half_rhythm"><div>Recurrent bronchitis</div></li><li class="half_rhythm"><div>Thrombocytopenia, marrow hypocellularity</div></li></ul>
</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Poikiloderma localized to face</div></li><li class="half_rhythm"><div>Hypohidrosis</div></li><li class="half_rhythm"><div>Muscle contractures</div></li><li class="half_rhythm"><div>Lymphedema of the extremities</div></li><li class="half_rhythm"><div>Myopathy</div></li><li class="half_rhythm"><div>Exocrine pancreatic insufficiency</div></li><li class="half_rhythm"><div>Pulmonary fibrosis</div></li></ul>
</td></tr><tr><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cyclic-n/"><i>ELANE</i>-related neutropenia</a></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ELANE</i></td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital neutropenia</div></li></ul>
</td><td headers="hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_1_4 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_2_2 hd_h_poikiloderma-n.T.disorders_to_consider_i_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cyclic neutropenia</div></li><li class="half_rhythm"><div>Severe neutropenia</div></li><li class="half_rhythm"><div>Absence of poikiloderma</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AML = acute myelogenous leukemia</p></div></dd><dt></dt><dd><div><p class="no_margin">SCC = squamous cell carcinoma</p></div></dd></dl></div></div></div></div><div id="poikiloderma-n.Management"><h2 id="_poikiloderma-n_Management_">Management</h2><div id="poikiloderma-n.Evaluations_Following_Ini"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with poikiloderma with neutropenia, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Dermatologic evaluation to confirm poikiloderma, assess calcinosis cutis and palmar/plantar hyperkeratosis, and screen for skin cancer</div></li><li class="half_rhythm"><div>Baseline complete blood count with differential and platelet count, if not done at the time of diagnosis</div></li><li class="half_rhythm"><div>Hematology/oncology consultation to evaluate need for bone marrow examination (e.g., if more than one cell line is involved)</div></li><li class="half_rhythm"><div>Baseline pulmonary evaluation to include evaluation for bronchiectasis and granulomas and to manage reactive airway disease</div></li><li class="half_rhythm"><div>Otolaryngology evaluation to evaluate complications of chronic otitis media</div></li><li class="half_rhythm"><div>For children, pediatric endocrinology evaluation to assess growth and pubertal development</div></li><li class="half_rhythm"><div>Gastrointestinal evaluation if hepatosplenomegaly and/or elevated liver transaminases are present</div></li><li class="half_rhythm"><div>Dental evaluation for evidence of gingivitis and/or caries</div></li><li class="half_rhythm"><div>Consideration of dual-energy x-ray absorptiometry (DXA) to evaluate for low bone density in adults</div></li><li class="half_rhythm"><div>Developmental evaluation for children younger than age five years</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist familiar with poikiloderma with neutropenia</div></li></ul></div><div id="poikiloderma-n.Treatment_of_Manifestatio"><h3>Treatment of Manifestations</h3><p><b>Palmar/plantar hyperkeratosis</b> if very pruritic &#x02012; and if there is no evidence of secondary dermatophyte infection &#x02012; can be treated for short periods with a strong topical steroid such as fluocinonide or clobetasol ointment two or three times a day. Other possible treatments include a topical keratolytic such as 40% urea, compounded salicylic acid mixed in cream, or propylene glycol.</p><p><b>Sinopulmonary, middle ear, and skin infections</b> should be treated aggressively with antibiotics until clinical resolution and normalization of inflammatory markers.</p><p>For individuals with recurrent sinopulmonary infections, use of prophylactic antibiotics during the winter may decrease frequency of infections [Author, personal observation].</p><p>There is no rationale for immunoglobulin therapy in the absence of low immunoglobulin levels.</p><p><b>Neutropenia.</b> Although administration of granulocyte-colony stimulating factor (G-CSF) to patients with PN increases the absolute neutrophil count (ANC), no reports to date have indicated definitive benefit [<a class="bk_pop" href="#poikiloderma-n.REF.migliaccio.1999.834">Migliaccio et al 1999</a>, <a class="bk_pop" href="#poikiloderma-n.REF.van_hove.2005.152">Van Hove et al 2005</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.rodgers.2013.665">Rodgers et al 2013</a>]. Based on lack of evidence of definitive benefit, G-CSF use may be considered only in patients with severe infections associated to very low neutrophil count.</p><p><b>Bone marrow abnormalities</b> (e.g., premyelodysplastic changes) should be followed and managed by the consulting hematologist/oncologist. Management of myelodysplastic syndrome and acute myelogenous leukemia is per routine.</p><p><b>Delayed puberty caused by hypogonadotropic hypogonadism</b> should be managed by an endocrinologist specialized in this condition and may include hormone replacement therapy.</p><p><b>Growth.</b> There is no evidence that growth hormone therapy increases linear growth.</p></div><div id="poikiloderma-n.Prevention_of_Secondary_C"><h3>Prevention of Secondary Complications</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Annual influenza vaccine as per standard of care</div></li><li class="half_rhythm"><div>Dental cleaning and evaluation for gingivitis/caries every 3-6 months</div></li><li class="half_rhythm"><div>Use of sunscreens with both UVA and UVB protection to reduce the risk of skin cancer</div></li></ul></div><div id="poikiloderma-n.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div><b>Annual evaluation</b></div><ul><li class="half_rhythm"><div>By a physician familiar with poikiloderma with neutropenia</div></li><li class="half_rhythm"><div>Of CBC with differential and platelet count for evidence of anemia and/or thrombocytopenia (signs of possible myelodysplastic syndrome) which would prompt a referral to a hematologist/oncologist for consideration of bone marrow examination</div></li><li class="half_rhythm"><div>By a pulmonologist for patients with bronchiectasis, chronic cough, and/or reactive airway disease</div></li><li class="half_rhythm"><div>By a dermatologist (starting at age 10 years) for skin cancer screening</div></li></ul></li><li class="half_rhythm"><div><b>Routine monitoring in children.</b> Growth, developmental milestones, school progress, and pubertal development</div></li></ul></div><div id="poikiloderma-n.AgentsCircumstances_to_Av"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Excessive sun exposure (to decrease the risk for skin cancer)</div></li><li class="half_rhythm"><div>Exposure to second-hand cigarette or wood smoke and persons with respiratory illnesses (to decrease the risk of respiratory infections)</div></li></ul></div><div id="poikiloderma-n.Evaluation_of_Relatives_a"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from prompt initiation of treatment and surveillance for potential complications.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <i>USB1</i> pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div>The following if the pathogenic variants in the family are not known:</div><ul><li class="half_rhythm"><div>Examination by a clinician familiar with poikiloderma with neutropenia to evaluate for the characteristic skin changes</div></li><li class="half_rhythm"><div>CBC with differential and platelet count especially in newborn sibs who have not manifested a skin rash</div></li></ul></li></ul><p>See <a href="#poikiloderma-n.Related_Genetic_Counselin">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="poikiloderma-n.Therapies_Under_Investiga"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="poikiloderma-n.Genetic_Counseling"><h2 id="_poikiloderma-n_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="poikiloderma-n.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Poikiloderma with neutropenia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="poikiloderma-n.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>USB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with poikiloderma with neutropenia are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>USB1</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>USB1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="poikiloderma-n.Carrier_Heterozygote_Dete"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>USB1</i> pathogenic variants in the family.</p></div><div id="poikiloderma-n.Related_Genetic_Counselin"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#poikiloderma-n.Evaluation_of_Relatives_a">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="poikiloderma-n.Prenatal_Testing_and_Prei"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>USB1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for poikiloderma are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="poikiloderma-n.Resources"><h2 id="_poikiloderma-n_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Neutropenia Network: North America Patient and Family Support Group</b></div><div>PO Box 1693</div><div>Brighton MI 48116</div><div><b>Phone:</b> 877-326-7117</div><div><b>Email:</b> kate@neutropenianet.org</div><div><a href="https://www.neutropenianet.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.neutropenianet.org</a></div></li><li class="half_rhythm"><div><b>Neutropenia Support Association Inc.: Canada Patient and Family Support Group </b></div><div>971 Corydon Avenue</div><div>P.O. Box 243</div><div>Winnipeg Manitoba R3M 3SR</div><div>Canada</div><div><b>Phone:</b> 204-489-8454; 800-663-8876 (within Canada and U.S.)</div><div><b>Email:</b> stevensl@neutropenia.ca</div><div><a href="https://www.neutropenia.ca/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.neutropenia.ca</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>Severe Chronic Neutropenia International Registry: Australia, India, and Southeast Asia</b></div><div>St. Vincent&#x02019;s Hospital, Department of Medicine</div><div>Fitzroy Victoria 3065</div><div>Australia</div><div><b>Phone:</b> 61-3-9231-2574</div><div><b>Email:</b> ffirkin@bigpond.net.au</div></li><li class="half_rhythm"><div><b>Severe Chronic Neutropenia International Registry: Europe, Africa, and Middle East</b></div><div>Carl-Neuberg-Str., 30625</div><div>Hannover </div><div>Germany</div><div><b>Phone:</b> 49-511-546-0918</div><div><b>Fax:</b> 49-511-557-106</div><div><b>Email:</b> zeidler.cornelia@mh-hannover.de</div><div><a href="http://www.severe-chronic-neutropenia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Severe Chronic Neutropenia International Registry Hannover</a></div></li><li class="half_rhythm"><div><b>Severe Chronic Neutropenia International Registry: North and South America</b></div><div>1107 Northeast 45th Street</div><div>Suite 345</div><div>Seattle WA 98105</div><div><b>Phone:</b> 206-543-9749; 800-726-4463 (within U.S.)</div><div><b>Fax:</b> 206-543-3668</div><div><b>Email:</b> bolyard@uw.edu</div><div><a href="https://depts.washington.edu/registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Severe Chronic Neutropenia International Registry Seattle</a></div></li></ul></div><div id="poikiloderma-n.Molecular_Genetics"><h2 id="_poikiloderma-n_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="poikiloderma-n.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Poikiloderma with Neutropenia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK459118/table/poikiloderma-n.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__poikiloderma-n.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_poikiloderma-n.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_poikiloderma-n.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_poikiloderma-n.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_poikiloderma-n.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_poikiloderma-n.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_poikiloderma-n.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_poikiloderma-n.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/79650" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>USB1</i></a></td><td headers="hd_b_poikiloderma-n.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=79650" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q21</a></td><td headers="hd_b_poikiloderma-n.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BQ65" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">U6 snRNA phosphodiesterase</a></td><td headers="hd_b_poikiloderma-n.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/USB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">USB1 database</a></td><td headers="hd_b_poikiloderma-n.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=USB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">USB1</a></td><td headers="hd_b_poikiloderma-n.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=USB1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">USB1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="poikiloderma-n.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="poikiloderma-n.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Poikiloderma with Neutropenia (<a href="/omim/604173,613276" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK459118/table/poikiloderma-n.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__poikiloderma-n.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604173" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604173</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POIKILODERMA WITH NEUTROPENIA; PN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613276" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613276</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">U6 SMALL NUCLEAR RNA BIOGENESIS PHOSPHODIESTERASE 1; USB1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>USB1</i> (previously known as <i>C16orf57</i>) is approximately 20 kb in size and comprises seven exons (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NG_027698.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NG_027698.1</a>). The major transcript USB1-001 (<a href="http://www.ensembl.org/Homo_sapiens/Transcript/Summary?g=ENSG00000103005;r=16:58001373-58021618;t=ENST00000219281" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000219281.7</a>) encodes a 265-amino acid protein, called USB1 or hMPN1 (mutated in PN 1). Besides the canonic transcript, several <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are expressed, among which the alternative USB1-004 (<a href="http://www.ensembl.org/Homo_sapiens/Transcript/Summary?g=ENSG00000103005;r=16:58001407-58011708;t=ENST00000423271" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000423271</a>) transcript containing the first three exons and a fourth alternative <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4, encodes a 186-amino acid protein that is expressed in keratinocytes, melanocytes, and fibroblasts [<a class="bk_pop" href="#poikiloderma-n.REF.arnold.2010.866">Arnold et al 2010</a>]. See <a href="/books/NBK459118/#poikiloderma-n.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> To date, 23 pathogenic variants have been reported. They include frameshifts (7) and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> (7), <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> (6), and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> (3) variants (see <a class="figpopup" href="/books/NBK459118/figure/poikiloderma-n.F4/?report=objectonly" target="object" rid-figpopup="figpoikilodermanF4" rid-ob="figobpoikilodermanF4">Figure 4</a>) [<a class="bk_pop" href="#poikiloderma-n.REF.larizza.2013.21">Larizza et al 2013</a>, <a class="bk_pop" href="#poikiloderma-n.REF.suter.2016.359">Suter et al 2016</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2016.1180">Walne et al 2016</a>, <a class="bk_pop" href="#poikiloderma-n.REF.aglaguel.2017.357">Aglaguel et al 2017</a>].</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figpoikilodermanF4" co-legend-rid="figlgndpoikilodermanF4"><a href="/books/NBK459118/figure/poikiloderma-n.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figpoikilodermanF4" rid-ob="figobpoikilodermanF4"><img class="small-thumb" src="/books/NBK459118/bin/poikiloderma-n-Image004.gif" src-large="/books/NBK459118/bin/poikiloderma-n-Image004.jpg" alt="Figure 4. . Schematic of reported USB1 pathogenic variants (exons are shown as numbered boxes)." /></a><div class="icnblk_cntnt" id="figlgndpoikilodermanF4"><h4 id="poikiloderma-n.F4"><a href="/books/NBK459118/figure/poikiloderma-n.F4/?report=objectonly" target="object" rid-ob="figobpoikilodermanF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Schematic of reported <i>USB1</i> pathogenic variants (exons are shown as numbered boxes). Nonsense variants are in black, frameshift in blue, splicing in violet, and missense variants in red. Note: The asterisked (*) missense (red) variant is &#x02013; by transcript <a href="/books/NBK459118/figure/poikiloderma-n.F4/?report=objectonly" target="object" rid-ob="figobpoikilodermanF4">(more...)</a></p></div></div><p>To date, all reported pathogenic variants appear to act by a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism. This applies also to the p.His208Arg <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant that affects the "signature" histidine of the second motif His208-Leu-Ser210-Leu, altering the catalytic site, and to the c.502A&#x0003e;G variant, which interferes with <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and induces <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> skipping.</p><p>Due to the high rate of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> observed in parents of individuals with PN, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (50/56; 89%) were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for <i>USB1</i> pathogenic variants and only a few (6/56; 11%) were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a>. This finding reflects the geographic clustering of variants driven by a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> and should be considered in the molecular diagnostics of different populations.</p><p>Indeed, several pathogenic variants have been identified in multiple families of specific ethnicity:</p><ul><li class="half_rhythm"><div><b>c.531delA.</b> 12 unrelated Turkish families [<a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.koparir.2014.2535">Koparir et al 2014</a>, <a class="bk_pop" href="#poikiloderma-n.REF.patiroglu.2015.331">Patiroglu &#x00026; Akar 2015</a>, <a class="bk_pop" href="#poikiloderma-n.REF.kilic.2016.e75">Kilic &#x00026; Cekic 2016</a>. <a class="bk_pop" href="#poikiloderma-n.REF.walne.2016.1180">Walne et al 2016</a>]</div></li><li class="half_rhythm"><div><b>c.499delA.</b> Four Athabaskan families [<a class="bk_pop" href="#poikiloderma-n.REF.clericuzio.2011.337">Clericuzio et al 2011</a>]</div></li><li class="half_rhythm"><div><b>p.(Trp81Ter).</b> Three northern European families [<a class="bk_pop" href="#poikiloderma-n.REF.arnold.2010.866">Arnold et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.walne.2010.4453">Walne et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.piard.2012.8">Piard et al 2012</a>]</div></li></ul><div id="poikiloderma-n.T.usb1_pathogenic_variant" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>USB1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK459118/table/poikiloderma-n.T.usb1_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__poikiloderma-n.T.usb1_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change&#x000a0;<sup>1</sup></th><th id="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change&#x000a0;<sup>1</sup></th><th id="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.179delC</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Pro60LeufsTer55)</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_024598.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024598<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_078874.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_078874<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.243G&#x0003e;A</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Trp81Ter)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.499delA</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Thr167ProfsTer98)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.502A&#x0003e;G&#x000a0;<sup>2</sup></td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Phe151_Arg168del)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.504-2A&#x0003e;C</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Thr169IlefsTer61)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.531delA</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(His179MetfsTer86)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.541C&#x0003e;T</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Gln181Ter)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.623A&#x0003e;G</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(His208Arg)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.673C&#x0003e;T</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Gln225Ter)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.683_693+1del12&#x000a0;<sup>3</sup></td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Asp204_Gln231del)</td></tr><tr><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.693+1G&#x0003e;T</td><td headers="hd_h_poikiloderma-n.T.usb1_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Asp204_Gln231del)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="poikiloderma-n.TF.3.1"><p class="no_margin">See <a class="figpopup" href="/books/NBK459118/figure/poikiloderma-n.F4/?report=objectonly" target="object" rid-figpopup="figpoikilodermanF4" rid-ob="figobpoikilodermanF4">Figure 4</a> for the other 12 "<a class="def" href="/books/n/gene/glossary/def-item/private/">private</a>" pathogenic variants that are not listed here.</p></div></dd><dt>2. </dt><dd><div id="poikiloderma-n.TF.3.2"><p class="no_margin">Apparent <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variation identified by transcript analysis as affecting <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> [<a class="bk_pop" href="#poikiloderma-n.REF.volpi.2010.72">Volpi et al 2010</a>]</p></div></dd><dt>3. </dt><dd><div id="poikiloderma-n.TF.3.3"><p class="no_margin">Apparent frameshift variation identified by transcript analysis as affecting <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> [<a class="bk_pop" href="#poikiloderma-n.REF.volpi.2010.72">Volpi et al 2010</a>]</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>USB1</i> encodes a protein of 265 amino acids called USB1 (Mpn1), a recognized member of the 2H-phosphodiesterase family owing to its twofold-pseudosymmetric structure with a central active site, and its two conserved tetrapeptid motifs (His<sub>120</sub>LeuSer<sub>122</sub>Leu and His<sub>208</sub>LeuSer<sub>210</sub>Leu) that frame the catalytic site [<a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>].</p><p>USB1 is a 3'-5'RNA-exonuclease able to cleave and protect from exosome damage the 3' end of U6, a small highly conserved nuclear RNA involved in the <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> process [<a class="bk_pop" href="#poikiloderma-n.REF.mroczek.2012.1911">Mroczek et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.shchepachev.2012.855">Shchepachev et al 2012</a>, <a class="bk_pop" href="#poikiloderma-n.REF.hilcenko.2013.1028">Hilcenko et al 2013</a>].</p><p>A key role of USB1 in normal hematopoiesis has been suggested by modeling poikiloderma with neutropenia in zebrafish, as <i>USB1</i>-depleted embryos showed impaired commitment and differentiation of neutrophil progenitors [<a class="bk_pop" href="#poikiloderma-n.REF.colombo.2015.15814">Colombo et al 2015</a>] and defective <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of "myeloid" genes [<a class="bk_pop" href="#poikiloderma-n.REF.patil.2015.426">Patil et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>USB1</i> pathogenic variants cause disease through a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism. Transcripts from abnormal <i>USB1</i> alleles, including those resulting from early truncating variants, are detectable and thus both relatively stable and translatable [<a class="bk_pop" href="#poikiloderma-n.REF.volpi.2010.72">Volpi et al 2010</a>, <a class="bk_pop" href="#poikiloderma-n.REF.clericuzio.2011.337">Clericuzio et al 2011</a>, <a class="bk_pop" href="#poikiloderma-n.REF.colombo.2012.7">Colombo et al 2012</a>, Unpublished data].</p><p>All reported pathogenic variants directly or indirectly affect the enzymatic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein by either deleting one or both key histidine-serine motifs (His<sub>120/208</sub> -X-Ser<sub>122/210</sub> &#x02013;X, where X indicates a hydrophobic residue) or destroying the native fold and the pseudosymmetrical structure of the protein.</p><p>The mechanistic basis of poikiloderma with neutropenia (i.e., the cascade of events primed by the aberrant oligoadenylation of U6 snRNA) remains to be elucidated [<a class="bk_pop" href="#poikiloderma-n.REF.mason.2013.872">Mason &#x00026; Bessler 2013</a>]. Tissue-specific <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> could be an adjunct key to discerning the differential sensitivity of the skin and the hematopoietic tissues, possibly revealing their contribution to constitutional disease and cancer.</p><p>Transient thrombocytopenia and variable anemia have been recapitulated in zebrafish <i>Usb1</i> morphants [<a class="bk_pop" href="#poikiloderma-n.REF.colombo.2015.15814">Colombo et al 2015</a>], suggesting that PN has more global bone marrow involvement.</p></div><div id="poikiloderma-n.References"><h2 id="_poikiloderma-n_References_">References</h2><div id="poikiloderma-n.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.aglaguel.2017.357">Aglaguel A, Abdelgghaffar H, Ailal F, Habti N, Hesse S, Kohistani N, Klein C, Bousfiha AA. Poikiloderma with neutropenia in Morocco: a report of 4 cases. <span><span class="ref-journal">J Clin Immunol. </span>2017;<span class="ref-vol">37</span>:357–62.</span> [<a href="/pubmed/28353165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28353165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.arnold.2010.866">Arnold AW, Itin PH, Pigors M, Kohlhase J, Bruckner-Tuderman L, Has C. Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria. <span><span class="ref-journal">Br J Dermatol. </span>2010;<span class="ref-vol">163</span>:866–9.</span> [<a href="/pubmed/20618321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20618321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.chantorn.2012.463">Chantorn R, Shwayder T. Poikiloderma with neutropenia: report of three cases including one with calcinosis cutis. <span><span class="ref-journal">Pediatr Dermatol. </span>2012;<span class="ref-vol">29</span>:463–72.</span> [<a href="/pubmed/21967010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21967010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.clericuzio.1991.a661">Clericuzio C, Hoyme HE, Asse JM. Immune deficient poikiloderma: a new genodermatosis. <span><span class="ref-journal">Am J Hum Genet. </span>1991;<span class="ref-vol">49</span> Suppl:A661.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.clericuzio.2011.337">Clericuzio C, Harutyunyan K, Jin W, Erickson RP, Irvine AD, McLean WH, Wen Y, Bagatell R, Griffin TA, Shwayder TA, Plon SE, Wang LL. Identification of a novel C16orf57 mutation in Athabaskan patients with poikiloderma with neutropenia. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:337–42.</span> [<a href="/pmc/articles/PMC3069503/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3069503</span></a>] [<a href="/pubmed/21271650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21271650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.colombo.2012.7">Colombo EA, Bazan JF, Negri G, Gervasini C, Elcioglu NH, Yucelten D, Altunay I, Cetincelik U, Teti A, Del Fattore A, Luciani M, Sullivan SK, Yan AC, Volpi L, Larizza L. Novel C16orf57 mutations in patients with poikiloderma with neutropenia: bioinformatic analysis of the protein and predicted effects of all reported mutations. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2012;<span class="ref-vol">7</span>:7.</span> [<a href="/pmc/articles/PMC3315733/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3315733</span></a>] [<a href="/pubmed/22269211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22269211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.colombo.2015.15814">Colombo EA, Carra S, Fontana L, Bresciani E, Cotelli F, Larizza L. A zebrafish model of poikiloderma with neutropenia recapitulates the human syndrome hallmarks and traces back neutropenia to the myeloid progenitor. <span><span class="ref-journal">Scientific Reports. </span>2015;<span class="ref-vol">5</span>:15814.</span> [<a href="/pmc/articles/PMC4629135/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4629135</span></a>] [<a href="/pubmed/26522474" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26522474</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.concolino.2010.2588">Concolino D, Roversi G, Muzzi GL, Sestito S, Colombo EA, Volpi L, Larizza L, Strisciuglio P. Clericuzio-type poikiloderma with neutropenia syndrome in three sibs with mutations in the C16orf57 gene: delineation of the phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2588–94.</span> [<a href="/pubmed/20734427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20734427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.farruggia.2014.297">Farruggia P, Indaco S, Dufour C, Lanza T, Mosa C, Macaluso A, Milioto M, D'Angelo P, Lanciotti M. Poikiloderma with neutropenia: a case report and review of the literature. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2014;<span class="ref-vol">36</span>:297–300.</span> [<a href="/pubmed/23823120" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23823120</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.hilcenko.2013.1028">Hilcenko C, Simpson PJ, Finch AJ, Bowler FR, Churcher MJ, Jin L, Packman LC, Shlien A, Campbell P, Kirwan M, Dokal I, Warren AJ. Aberrant 3' oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">121</span>:1028–38.</span> [<a href="/pubmed/23190533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23190533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.kilic.2016.e75">Kilic SS, Cekic S. Juvenile idiopathic inflammatory myopathy in a patient with dyskeratosis congenita due to C16orf57 mutation. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2016;<span class="ref-vol">38</span>:e75–7.</span> [<a href="/pubmed/26535771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26535771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.koparir.2014.2535">Koparir A, Gezdirici A, Koparir E, Ulucan H, Yilmaz M, Erdemir A, Yuksel A, Ozen M. Poikiloderma with neutropenia: genotype-ethnic origin correlation, expanding phenotype and literature review. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:2535–40.</span> [<a href="/pubmed/25044170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25044170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.larizza.2013.21">Larizza L, Negri G, Colombo EA, Volpi L, Sznajer Y. Clinical utility gene card for: poikiloderma with neutropenia. <span><span class="ref-journal">Eur J Hum Genet. </span>2013:21.</span> [<a href="/pmc/articles/PMC3778337/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3778337</span></a>] [<a href="/pubmed/23321617" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23321617</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.mason.2013.872">Mason PJ, Bessler M. Poikiloderma with neutropenia: beginning at the end. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">121</span>:872–4.</span> [<a href="/pubmed/23393019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23393019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.migliaccio.1999.834">Migliaccio S, Luciani M, Taranta A, De Rossi G, Minisola S, El Hachem M, Bosman C, De Felice L, Boldrini R, Corsi A, Bianco P, Teti A. Association of intermediate osteopetrosis with poikiloderma. <span><span class="ref-journal">J Bone Miner Res. </span>1999;<span class="ref-vol">14</span>:834–6.</span> [<a href="/pubmed/10320533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10320533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.mostefai.2008.2762">Mostefai R, Morice-Picard F, Boralevi F, Sautarel M, Lacombe D, Stasia MJ, McGrath J, Taieb A. Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2762–9.</span> [<a href="/pubmed/18925663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18925663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.mroczek.2012.1911">Mroczek S, Krwawicz J, Kutner J, Lazniewski M, Kuci&#x00144;ski I, Ginalski K, Dziembowski A. C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3' end modification. <span><span class="ref-journal">Genes Dev. </span>2012;<span class="ref-vol">26</span>:1911–25.</span> [<a href="/pmc/articles/PMC3435495/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3435495</span></a>] [<a href="/pubmed/22899009" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22899009</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.patil.2015.426">Patil P, Uechi T, Kenmochi N. Incomplete splicing of neutrophil-specific genes affects neutrophil development in a zebrafish model of poikiloderma with neutropenia. <span><span class="ref-journal">RNA Biol. </span>2015;<span class="ref-vol">12</span>:426–34.</span> [<a href="/pmc/articles/PMC4615382/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4615382</span></a>] [<a href="/pubmed/25849198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25849198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.patiroglu.2015.331">Patiroglu T, Akar HH. Clericuzio-type poikiloderma with neutropenia syndrome in a Turkish family: a three report of siblings with mutation in the C16orf57 gene. <span><span class="ref-journal">Iran J Allergy Asthma Immunol. </span>2015;<span class="ref-vol">14</span>:331–7.</span> [<a href="/pubmed/26546903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26546903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.pianigiani.2001.422">Pianigiani E, De Aloe G, Andreassi A, Rubegni P, Fimiani M. Rothmund-Thomson syndrome (Thomson type) and myelodysplasia. <span><span class="ref-journal">Pediatr Dermatol. </span>2001;<span class="ref-vol">18</span>:422–5.</span> [<a href="/pubmed/11737690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11737690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.piard.2012.8">Piard J, Holder-Espinasse M, Aral B, Gigot N, Rio M, Tardieu M, Puzenat E, Goldenberg A, Toutain A, Franques J, MacDermot K, Bessis D, Boute O, Callier P, Gueneau L, Huet F, Vabres P, Catteau B, Faivre L, Thauvin-Robinet C. Systematic search for neutropenia should be part of the first screening in patients with poikiloderma. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:8–11.</span> [<a href="/pubmed/21872685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21872685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.porter.1999.452">Porter WM, Hardman CM, Abdalla SH, Powles AV. Haematological disease in siblings with Rothmund-Thomson syndrome. <span><span class="ref-journal">Clin Exp Dermatol. </span>1999;<span class="ref-vol">24</span>:452–4.</span> [<a href="/pubmed/10606946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10606946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.rodgers.2013.665">Rodgers W, Ancliff P, Ponting CP, Sanchez-Pulido L, Burns S, Hayman M, Kimonis V, Sebire N, Bulstrode N, Harper JI. Squamous cell carcinoma in a child with Clericuzio-type poikiloderma with neutropenia. <span><span class="ref-journal">Br J Dermatol. </span>2013;<span class="ref-vol">168</span>:665–7.</span> [<a href="/pubmed/22924337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22924337</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.shchepachev.2012.855">Shchepachev V, Wischnewski H, Missiaglia E, Soneson C, Azzalin CM. Mpn1, mutated in poikiloderma with neutropenia protein 1, is a conserved 3'-to-5' RNA exonuclease processing U6 small nuclear RNA. <span><span class="ref-journal">Cell Rep. </span>2012;<span class="ref-vol">2</span>:855–65.</span> [<a href="/pubmed/23022480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23022480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.suter.2016.359">Suter AA, Itin P, Heinimann K, Ahmed M, Ashraf T, Fryssira H, Kini U, Lapunzina P, Miny P, Sommerlund M, Suri M, Vaeth S, Vasudevan P, Gallati S. Rothmund-Thomson Syndrome: novel pathogenic mutations and frequencies of variants in the RECQL4 and USB1 (C16orf57) gene. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2016;<span class="ref-vol">4</span>:359–66.</span> [<a href="/pmc/articles/PMC4867568/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4867568</span></a>] [<a href="/pubmed/27247962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27247962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.tanaka.2010.1347">Tanaka A, Morice-Picard F, Lacombe D, Nagy N, Hide M, Ta&#x000ef;eb A, McGrath J. Identification of a homozygous deletion mutation in C16orf57 in a family with Clericuzio-type poikiloderma with neutropenia. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:1347–8.</span> [<a href="/pubmed/20503306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20503306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.van_hove.2005.152">Van Hove JL, Jaeken J, Proesmans M, Boeck KD, Minner K, Matthijs G, Verbeken E, Demunter A, Boogaerts M. Clericuzio type poikiloderma with neutropenia is distinct from Rothmund-Thomson syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">132A</span>:152–8.</span> [<a href="/pubmed/15558713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15558713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.volpi.2010.72">Volpi L, Roversi G, Colombo EA, Leijsten N, Concolino D, Calabria A, Mencarelli MA, Fimiani M, Macciardi F, Pfundt R, Schoenmakers EF, Larizza L. Targeted next-generation sequencing appoints C16orf57 as Clericuzio-type poikiloderma with neutropenia gene. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:72–6.</span> [<a href="/pmc/articles/PMC2801743/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2801743</span></a>] [<a href="/pubmed/20004881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20004881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.walne.2010.4453">Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I. Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:4453–61.</span> [<a href="/pmc/articles/PMC2957322/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2957322</span></a>] [<a href="/pubmed/20817924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20817924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.walne.2016.1180">Walne AJ, Collopy L, Cardoso S, Ellison A, Plagnol V, Albayrak C, Albayrak D, Kilic SS, Pat&#x00131;roglu T, Akar H, Godfrey K, Carter T, Marafie M, Vora A, Sundin M, Vulliamy T, Tummala H, Dokal I. Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis. <span><span class="ref-journal">Haematologica. </span>2016;<span class="ref-vol">101</span>:1180–9.</span> [<a href="/pmc/articles/PMC5046647/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5046647</span></a>] [<a href="/pubmed/27612988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27612988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="poikiloderma-n.REF.wang.2003.299">Wang LL, Gannavarapu A, Clericuzio CL, Erickson RP, Irvine AD, Plon SE. Absence of RECQL4 mutations in poikiloderma with neutropenia in Navajo and non-Navajo patients. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">118A</span>:299–301.</span> [<a href="/pubmed/12673665" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12673665</span></a>]</div></li></ul></div></div><div id="poikiloderma-n.Chapter_Notes"><h2 id="_poikiloderma-n_Chapter_Notes_">Chapter Notes</h2><div id="poikiloderma-n.Author_Notes"><h3>Author Notes</h3><p>Dr Wang is a pediatric oncologist at Texas Children's Cancer Center with particular interest in treating children with solid tumors, particularly osteosarcoma. She has a longstanding interest in Rothmund-Thomson syndrome and related disorders.</p><p>Dr Clericuzio is a clinical geneticist/dysmorphologist at University of New Mexico Health Sciences Center with an interest in cancer syndromes. She was the first to identify PN as a unique disorder in 1991.</p><p>Dr Larizza is a former professor of Medical Genetics at the University of Milan with a long-lasting interest in rare diseases, particularly cancer-predisposing syndromes. In 2010 her group identified <i>C16orf57/USB1</i> as the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved in Clericuzio-type poikiloderma with neutropenia.</p></div><div id="poikiloderma-n.Acknowledgments"><h3>Acknowledgments</h3><p>We thank Dr D Concolino for providing the patient photographs in <a class="figpopup" href="/books/NBK459118/figure/poikiloderma-n.F3/?report=objectonly" target="object" rid-figpopup="figpoikilodermanF3" rid-ob="figobpoikilodermanF3">Figure 3</a> and the families who have generously shared their information.</p><p>We thank Dr EA Colombo (curator of the <i>USB1</i> LOVD) for assistance in updating the <i>USB1</i> pathogenic variants.</p></div><div id="poikiloderma-n.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>26 October 2017 (bp) Review posted live</div></li><li class="half_rhythm"><div>19 December 2016 (lw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK459118</span><span class="label">PMID: <a href="/pubmed/29072891" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29072891</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pitt-hopkins/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pkd-ad/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK459118&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK459118/?report=reader">PubReader</a></li><li><a href="/books/NBK459118/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK459118" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK459118" style="display:none" title="Cite this Page"><div class="bk_tt">Wang L, Clericuzio C, Larizza L. Poikiloderma with Neutropenia. 2017 Oct 26. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK459118/pdf/Bookshelf_NBK459118.pdf">PDF version of this page</a> (1.1M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#poikiloderma-n.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#poikiloderma-n.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#poikiloderma-n.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#poikiloderma-n.Genetically_Related_Allel" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#poikiloderma-n.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#poikiloderma-n.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#poikiloderma-n.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#poikiloderma-n.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#poikiloderma-n.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#poikiloderma-n.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#poikiloderma-n.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79650[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">USB1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4459562" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4459562" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4459562" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4459562" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25879134" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> G6PC3 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> G6PC3 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Banka S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301705" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ELANE</i>-Related Neutropenia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ELANE</i>-Related Neutropenia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dale DC, Makaryan V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301444" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alström Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Paisey RB, Steeds R, Barrett T, Williams D, Geberhiwot T, Gunay-Aygun M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301722" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nelson A, Myers K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29072891" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29072891" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041479dde0891169d1274c">Poikiloderma with Neutropenia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Poikiloderma with Neutropenia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:01:29-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A6614E040AE610000000003FE018D&amp;ncbi_session=CE8A6614E0414781_1022SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK459118%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK459118&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK459118/&amp;ncbi_pagename=Poikiloderma with Neutropenia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A6614E0414781_1022SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>